about
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated ...
Read More
313.08
3.25
(1.05%)
760.3K
XNAS Volume
XNAS 27 Jun, 2025 5:30 PM (EDT)
High Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
Insulet Corporation Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..